ReviewHeart failure reviews2013
Peripheral arterial disease and chronic heart failure: a dangerous mix.
Review in Heart failure reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.
- Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.European heart journal · 2023Pooled it
- Screening for peripheral arterial disease.The Cochrane database of systematic reviews · 2014Pooled it
- Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.The Cochrane database of systematic reviews · 2013Pooled it
- Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.Clinical cardiology · 2017Trial
- Autologous Cell Therapy for Chronic Limb Threatening Ischemia: Towards Personalized Medicine.Angiology · 2026Review
- The Glittre-ADL test cut off value to discriminate functional status in individuals with heart failure.Irish journal of medical science · 2026Article
- Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure.Internal and emergency medicine · 2025Article
- Obese have comparable ankle brachial pressure index but higher β-cell function and insulin resistance as compared to normal-weight type 2 diabetes mellitus patients.Acta diabetologica · 2025Article
- Effects of SGLT2 Inhibitors on Cardiovascular and Lower Limb Events in Patients with Type 2 Diabetes: A Nationwide Population-Based Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- The CorInnova Implantable Cardiac Assist System for Direct Cardiac Compression.Reviews in cardiovascular medicine · 2022Review
- Initial diastolic dysfunction is a powerful predictor of 5-year mortality in peripheral arterial disease patients undergoing percutaneous transluminal angioplasty.Heart and vessels · 2021Article
- Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure.JAMA cardiology · 2020Article
- Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012 - a nationwide study.BMC cardiovascular disorders · 2019Observational
- A New Clinically Applicable Measure of Functional Status in Patients With Heart Failure: The 60-Foot Walk Test.JACC. Heart failure · 2017Observational
- The CHAESC heart failure · 2016Article
- Mortality Risk Among Heart Failure Patients With Depression: A Nationwide Population-Based Cohort Study.Journal of the American Heart Association · 2016Article
- Modulating the vascular response to limb ischemia: angiogenic and cell therapies.Circulation research · 2015Review
- Article
- Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease.JRSM cardiovascular diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic heart failure (CHF) is associated with a high comorbidity burden, adverse impact on quality of life and high health care utilisation. Peripheral arterial disease (PAD) and CHF share many risk, pathophysiological and prognostic features, and each has been associated with increased morbidity and mortality. PAD often goes undetected, and yet in spite of the availability of screening tools, this is not commonly considered in CHF care. A review of the electronic databases Medline, CINAHL and Cochrane CENTRAL was undertaken using the MeSH terms peripheral arterial disease, peripheral vascular disease, intermittent claudication and heart failure to identify studies examining the prevalence and clinical outcomes of coexisting PAD in patients with CHF. Five studies were identified. There are limited data describing the impact of PAD on CHF outcomes. As PAD may contribute to decreased capacity to exercise and other self-care behaviours, identifying those at risk and providing appropriate therapy are important. Based on this review, patients who are smokers and those with diagnosed coronary heart disease and diabetes should be targeted for the screening of PAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.